Stopping GLP-1s raises complicated questions for pregnancy
Using popular weight-loss drugs like Ozempic during pregnancy is not recommended. But stopping the medications just before conception or in the early stages of pregnancy may come with some risks, according to a new study. And without further studies, say experts, the data paints a complicated picture of the relationship between GLP-1s and pregnancy. What […]
The dual GLP-1–glucagon agonist pemvidutide in MASH: a phase 2b trial
Publication date: 6–12 December 2025 Source: The Lancet, Volume 406, Issue 10520 Author(s): Frank Tacke
What to know about GLP-1 drugs and muscle loss
A recent KFF poll revealed that one in eight adults in the U.S. is currently taking a GLP-1 weight loss drug. As more people start using them, some are talking about the unexpected side effects, including muscle loss and weakness. Senior Vox correspondent Dylan Scott joins CBS News to share what patients told him. CBS […]
The GLP-1 Revolution: How a Diabetes Drug Became the Pharmaceutical Industry’s Hottest Asset
*A data-driven investigation into the clinical trial explosion that’s reshaping modern medicine* Continue reading on Medium »
Tirzepatide is Associated with Reduced Risk of Primary Open-Angle Glaucoma and Ocular Hypertension in Patients with Type 2 Diabetes
Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA), has shown superior efficacy in glycemic control, weight loss, and cardiometabolic outcomes compared to GLP-1 RAs alone. While GLP-1 RAs may offer neuroprotective effects relevant to glaucoma, the impact of dual-incretin therapies like tirzepatide on glaucoma remains unknown. This study investigates […]
Ozempic 2.0! Experts Call GLP-1 Pills a Game-Changer for Weight Loss—Here’s How They Work and When To Expect Them
Post Content
GLP-1 Drugs Like Ozempic Might Have a Side Effect Nobody Expected
A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are calling for more research.
Is ozempic forever? UK surgeon explains how GLP-1 drugs work, and whether you need to take them indefinitely
If you are considering GLP-1 drugs for weight loss, it might be a more serious commitment than you expected. Dr Rajan explains how they work.
Safety and effectiveness of tirzepatide during Ramadan fasting: Real‐world evidence from patients with type 2 diabetes in Bangladesh
Abstract Aims Ramadan fasting poses challenges for patients with type 2 diabetes mellitus (T2DM) due to increased risks of hypoglycemia and metabolic fluctuations. Tirzepatide, a dual GIP/GLP-1 receptor agonist, has shown marked efficacy in glycemic control and weight reduction. This study aimed to evaluate the safety and effectiveness of tirzepatide among Bangladeshi patients with T2DM […]
Unintentional periconceptional exposure to glucagon‐like peptide‐1 receptor agonists and adverse pregnancy outcomes: A nationwide cohort study in Taiwan
Abstract Aims To assess whether periconceptional exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with adverse outcomes in women with pregestational type 2 diabetes. Materials and Methods We linked Taiwan’s Birth Certificate Application and National Health Insurance claims (2013–2022) to assemble a nationwide cohort of singleton births to mothers (18–50 years) with pregestational diabetes. […]